Bridgebio Oncology Therapeutics Inc (BBOT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BBOT | CGEM | GYRE | ||
| Company | Bridgebio Oncology Therapeutics Inc | Cullinan Therapeutics Inc | Gyre Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.00 | 13.77 | 8.39 | ||
| High | 10.19 | 14.32 | 8.62 | ||
| Low | 9.80 | 13.41 | 8.20 | ||
| Latest | 9.98 | 13.65 | 8.28 | ||
| Change | -0.14 | -0.23 | -0.14 | ||
| % Change | -1.38% | -1.66% | -1.66% | ||
| Volume | 205,700 | 930,200 | 75,500 | ||
| 20-Day Average Volume | 286,500 | 720,730 | 61,735 | ||
| Previous Close | 10.12 | 13.88 | 8.42 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 11.51 | 12.31 | 8.00 | ||
| 20-Day Raw Stochastic | 4.30% | 77.38% | 70.91% | ||
| 20-Day Relative Strength | 40.96 | 62.26 | 55.91 | ||
| Weighted Alpha | -15.99 | +69.50 | -10.40 | ||
| Today's Opinion | 40% Sell | 100% Buy | 56% Buy | ||
| Previous Opinion | 40% Sell | 100% Buy | 56% Buy | ||
| Last Month's Opinion | 32% Buy | 100% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -12.61% since 02/12/26 | +16.77% since 02/12/26 | +5.88% since 02/12/26 | ||
| Low | 9.80 on 02/20/26 | 11.40 on 02/13/26 | 7.86 on 02/13/26 | ||
| High | 11.73 on 02/13/26 | 14.32 on 02/20/26 | 8.62 on 02/20/26 | ||
| 1-Month | |||||
| %Chg | -12.91% since 01/20/26 | +25.57% since 01/20/26 | +4.41% since 01/20/26 | ||
| Low | 9.80 on 02/20/26 | 10.78 on 01/21/26 | 7.45 on 02/05/26 | ||
| High | 13.99 on 01/27/26 | 14.32 on 02/20/26 | 8.62 on 02/20/26 | ||
| 3-Month | |||||
| %Chg | -18.06% since 11/20/25 | +56.54% since 11/20/25 | +10.55% since 11/20/25 | ||
| Low | 9.80 on 02/20/26 | 8.52 on 11/21/25 | 6.76 on 01/02/26 | ||
| High | 14.87 on 12/08/25 | 14.32 on 02/20/26 | 8.62 on 02/20/26 | ||
| 6-Month | |||||
| %Chg | +3.63% since 08/20/25 | +82.73% since 08/20/25 | +7.12% since 08/20/25 | ||
| Low | 8.70 on 08/22/25 | 5.68 on 10/03/25 | 6.76 on 01/02/26 | ||
| High | 14.87 on 12/08/25 | 14.32 on 02/20/26 | 9.42 on 10/16/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 798,290 | 806,387 | 797,637 | ||
| Shares Outstanding, K | 79,989 | 59,076 | 96,333 | ||
| Annual Sales | 0 | 0 | 105,760,000 | ||
| Annual Net Income | -74,275,000 | -167,380,000 | 12,090,000 | ||
| Last Quarter Sales | 0 | 0 | 30,560,000 | ||
| Last Quarter Net Income | -44,760,000 | -50,610,000 | 3,610,000 | ||
| 60-Month Beta | 0.12 | -0.09 | 1.97 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.03 on 11/12/25 | -0.77 on 11/06/25 | 0.06 on 11/07/25 | ||
| Latest Earnings Date | 02/25/26 | 02/26/26 | 03/16/26 | ||
| Most Recent Dividend | N/A | N/A | 0.569 on 08/20/15 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 105.25 | ||